NCT05448599 2023-03-15
A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Unknown
Mabwell (Shanghai) Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.